TimeScale Financial’s Bionano Genomics BNGO Stock Holding History

TimeScale Financial’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$334	Hold	1	–	–	﹤0.01%	586
2023 Q1	$608	Hold	1	–	–	﹤0.01%	556
2022 Q4	$1K	Hold	1	–	–	﹤0.01%	504
2022 Q3	$1K	Hold	1	–	–	﹤0.01%	481
2022 Q2	$1K	Hold	1	–	–	﹤0.01%	450
2022 Q1	$1K	Hold	1	–	–	﹤0.01%	473
2021 Q4	$2K	Hold	1	–	–	﹤0.01%	431
2021 Q3	$3K	Hold	1	–	–	﹤0.01%	408
2021 Q2	$4K	Hold	1	–	–	﹤0.01%	395
2021 Q1	$4K	Buy	+1	New	+$5.64K	﹤0.01%	394

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TimeScale Financial's BNGO Position: Q2 2023 in Review

TimeScale Financial held its Bionano Genomics (BNGO) position steady in Q2 2023 at 1 share worth $334. The position accounts for ﹤0.01% of the portfolio, ranked #586.

TimeScale Financial first reported a position in BNGO in Q1 2021 and has held it in 10 quarters since. The position peaked at $4K in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

TimeScale Financial held 1 share of Bionano Genomics worth $334 as of Q2 2023.
TimeScale Financial left its Bionano Genomics share count unchanged in Q2 2023.
Bionano Genomics made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #586 holding.
TimeScale Financial first reported a position in Bionano Genomics in Q1 2021 and has held it in 10 quarters since.
TimeScale Financial's Bionano Genomics position peaked at $4K in Q2 2021.
108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.